Bicara director awarded 19,475 stock options
Bicara Therapeutics Inc. director Michael Powell received a grant of stock options as part of his compensation.
Rhea-AI Filing Summary
Bicara Therapeutics Inc. director Michael Powell received a grant of stock options as part of his compensation. The award covers 19,475 options to buy common stock at an exercise price of $20.56 per share, expiring on June 9, 2036.
The options vest upon the earlier of June 9, 2027 or the date of the next annual meeting of stockholders, conditional on his continued service. After this grant, Powell holds 19,475 derivative securities directly, reflecting a routine equity incentive rather than an open-market purchase or sale.
Positive
- None.
Negative
- None.
Insider Trade Summary
Grant/Award: 19,475 shares
Grant/Award
1 txn
Insider
POWELL MICHAEL
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 19,475 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (Right to Buy) — 19,475 contracts (Direct)
Footnotes (1)
- F1. The shares underlying this stock option vest upon the earlier of (i) June 9, 2027 or (ii) the date of the next Annual Meeting of Stockholders of Bicara Therapeutics Inc., subject to the Reporting Person's continued service on such vesting date.
Key Figures
Options granted: 19,475 options
Exercise price: $20.56 per share
Expiration date: June 9, 2036
+3 more
6 metrics
Options granted
19,475 options
Stock Option (Right to Buy) grant to director
Exercise price
$20.56 per share
Conversion or exercise price for the options
Expiration date
June 9, 2036
Option term end date
Shares underlying options
19,475 shares
Underlying Bicara Therapeutics common stock
Post-transaction derivative holdings
19,475 options
Total stock options held following grant
Vesting date trigger
Earlier of June 9, 2027 or next annual meeting
Subject to continued service condition
Key Terms
Stock Option (Right to Buy), exercise price, expiration date, vesting, +1 more
5 terms
Stock Option (Right to Buy) financial
"security_title: "Stock Option (Right to Buy)""
exercise price financial
"conversion_or_exercise_price: "20.5600""
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
expiration date financial
"expiration_date: "2036-06-09T00:00:00.000Z""
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
vesting financial
"The shares underlying this stock option vest upon the earlier of"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
Annual Meeting of Stockholders financial
"the date of the next Annual Meeting of Stockholders of Bicara Therapeutics Inc."
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Bicara Therapeutics (BCAX) director Michael Powell report in this Form 4?
Michael Powell reported receiving a grant of stock options for 19,475 shares of Bicara Therapeutics common stock. These options are a compensation award, not an open-market trade, and give him the right to buy shares at a fixed exercise price if vesting conditions are met.
How many Bicara Therapeutics (BCAX) stock options were granted to Michael Powell?
Michael Powell was granted 19,475 stock options linked to Bicara Therapeutics common stock. All 19,475 options are shown as held following the transaction, indicating this filing records the full award rather than a partial change to an existing options position.
What is the exercise price and expiration date of Michael Powell’s BCAX options?
The stock options granted to Michael Powell have an exercise price of $20.56 per share and expire on June 9, 2036. This means he can choose to buy Bicara Therapeutics common stock at $20.56 any time after vesting and before the expiration date.
When do Michael Powell’s Bicara Therapeutics (BCAX) stock options vest?
The options vest on the earlier of June 9, 2027, or the date of the next annual meeting of stockholders. Vesting is also subject to Michael Powell’s continued service with Bicara Therapeutics through that vesting date, as disclosed in the footnote.
How is Michael Powell’s ownership reported after this BCAX stock option grant?
After the grant, Michael Powell is reported as directly holding 19,475 stock options relating to Bicara Therapeutics common stock. The filing does not show additional option exercises or share sales, so this award represents his reported derivative position in this specific Form 4.
AI-generated analysis. How Rhea-AI works. Not financial advice.
